Halozyme Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $46M | 42M | 1.08 |
| 2025-06-30 | $25M | 25M | 1.00 |
| 2025-03-31 | $5.3M | 5.0M | 1.06 |
| 2024-03-31 | $10M | 11M | 0.89 |
| 2023-12-31 | $14M | 16M | 0.87 |
| 2023-09-30 | $8.0M | 9.5M | 0.85 |
| 2023-03-31 | $5.1M | 6.0M | 0.85 |